Biomarker evaluation in radically resectable locally advanced gastric cancer treated with neoadjuvant chemotherapy: an evidence reappraisal

Neoadjuvant chemotherapy (NAC) significantly improved the prognosis of patients with locally advanced resectable gastric cancer but, despite important progresses, relapse-related death remains a major challenge. Therefore, it appears crucial to understand which patients will benefit from peri-operat...

Descripción completa

Detalles Bibliográficos
Autores principales: Gervaso, Lorenzo, Pellicori, Stefania, Cella, Chiara A., Bagnardi, Vincenzo, Lordick, Florian, Fazio, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8414610/
https://www.ncbi.nlm.nih.gov/pubmed/34484429
http://dx.doi.org/10.1177/17588359211029559

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8414610/
https://www.ncbi.nlm.nih.gov/pubmed/34484429
http://dx.doi.org/10.1177/17588359211029559

Ejemplares similares